Literature DB >> 7262979

Disturbances of calcium metabolism in the spontaneously hypertensive rat.

D A McCarron, N N Yung, B A Ugoretz, S Krutzik.   

Abstract

Ionized calcium is critical to the maintenance of normal cardiovascular function. Recently, vasoactive properties have also been attributed to parathyroid hormone (PTH). The present study characterizes the calcium-PTH axis in the spontaneously hypertensive rat (SHR) in order to determine the effects of chronic alterations in calcium intake on the development and maintenance of hypertension in this species. Thirty-six SHR and 36 Wistar-Kyoto (WKY) normotensive control rats were studied. The rats were fed one of three levels (percent of total diet) of calcium (normal 0.5%, low-normal 0.25%, high 4.0%) beginning at 10 weeks of age. Serum total and ionized calcium, serum PTHs, urinary electrolytes, and systolic blood pressures were assessed by repeated measurements between 10 and 48 weeks of age. Irrespective of calcium intake, the SHRs had lower serum ionized calcium concentrations (p less than 0.001) and higher PTH levels (p less than 0.001) than the WKYs. Serum total calcium were similar for the two strains. Urinary calcium excretion was greater in the SHR (p less than 0.001) relative to the WKY. The high (4.0%) calcium diet normalized the serum ionized calcium and attenuated the development of the SHRs' hypertension (p less than 0.001). The present study describes several previously unrecognized abnormalities of calcium metabolism in the SHR. These disturbances may be of pathogenetic importance in the development and maintenance of hypertension in the SHR.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7262979     DOI: 10.1161/01.hyp.3.3_pt_2.i162

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

1.  Impaired duodenal response to short-term dietary calcium restriction in adolescent spontaneously hypertensive rats.

Authors:  S Chabanis; P Duchambon; H Banide; P Aymard; B Lacour; T Drüeke
Journal:  Calcif Tissue Int       Date:  1993-04       Impact factor: 4.333

2.  Minerals in renal and SHR hypertensive rats.

Authors:  H F Loyke
Journal:  Biol Trace Elem Res       Date:  1990-04       Impact factor: 3.738

3.  Altered element concentrations in tissues of Dahl salt-sensitive rats.

Authors:  N Krari; P Allain
Journal:  Biol Trace Elem Res       Date:  1991-11       Impact factor: 3.738

4.  Increased calcium absorption in prehypertensive spontaneously hypertensive rat. Role of serum 1,25-dihydroxyvitamin D3 levels and intestinal brush border membrane fluidity.

Authors:  K Lau; C B Langman; U Gafter; P K Dudeja; T A Brasitus
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

5.  Altered vitamin D metabolism in the kidney of the spontaneously hypertensive rat.

Authors:  H Kawashima
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

6.  Prolactin and calcium metabolism: influence of hyperprolactinemia on immunoreactive parathyroid hormone levels in man and in the rat.

Authors:  C E Fiore; R D'Agata; G Clementi; L S Malatino
Journal:  J Endocrinol Invest       Date:  1984-12       Impact factor: 4.256

7.  Bone disorders in spontaneously hypertensive rat.

Authors:  Y Izawa; K Sagara; T Kadota; T Makita
Journal:  Calcif Tissue Int       Date:  1985-12       Impact factor: 4.333

8.  Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats.

Authors:  Gabriel Mulinari-Santos; Jaqueline Silva Dos Santos; Letícia Pitol Palin; Ana Cláudia Ervolino da Silva; Cristina Antoniali; Leonardo Perez Faverani; Roberta Okamoto
Journal:  J Appl Oral Sci       Date:  2019-10-07       Impact factor: 2.698

9.  Alveolar bone healing in rats: micro-CT, immunohistochemical and molecular analysis.

Authors:  Jaqueline Suemi Hassumi; Gabriel Mulinari-Santos; André Luis da Silva Fabris; Ricardo Garcia Mureb Jacob; Alaíde Gonçalves; Ana Cláudia Rossi; Alexandre Rodrigues Freire; Leonardo Pérez Faverani; Roberta Okamoto
Journal:  J Appl Oral Sci       Date:  2018-06-18       Impact factor: 2.698

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.